Nidec Announces the Status of Own Share Repurchase
(Repurchase of own shares, pursuant to the Company’s Articles of Incorporation based on the provisions of Item 1 of Article 459 (1) of the Companies Act of Japan)
KYOTO, Japan--(BUSINESS WIRE)-- Nidec Corporation (TOKYO:6594; OTC US: NJDCY) (the “Company”) today announced the status of the Company’s own share repurchase under its ongoing repurchase plan resolved at a meeting of the Board of Directors held on July 23, 2024, pursuant to Item 1 of Article 459 (1) of the Companies Act of Japan.
Details of Share Repurchase
- Period of own share repurchase: From September 1, 2024 through September 30, 2024
- Class of shares: Common stock
- Number of own shares repurchased: 0
- Total repurchase amount: 0 yen
Note: The above repurchase information has been prepared on the basis of trade date.
Reference
A) Details of the share repurchase plan authorized by the Board of Directors on July 23, 2024:
- Class of shares: Common stock
- Total number of shares that may be repurchased: Up to 10,000,000 shares (0.87% of total number of shares issued, excluding treasury stock)
- Total repurchasable amount: 35 billion yen
- Period of repurchase: From May 27, 2024 through May 26, 2025
B) Total number and yen amount of own shares repurchased from May 27, 2024 through September 30, 2024, pursuant to the Board of Directors resolution above:
- Total number of own shares repurchased: 0
- Total repurchase amount: 0 yen
View source version on businesswire.com: https://www.businesswire.com/news/home/20240930417331/en/
Teruaki Urago
General Manager
Investor Relations
+81-75-935-6140
[email protected]
Source: Nidec Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ivonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer in HARMONi-GI1 S
- BNB Price Prediction: Can BNB Reach $850 as Remittix Prepares Its $0.46 Final Presale Stage?
- Cardano Price Today: ADA Near $0.203 as Remittix Prepares to Remove 300M RTX From Total Supply
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share